Literature DB >> 28594077

Trends in antidepressant prescribing to children and adolescents in Canadian primary care: A time-series analysis.

Rachael Morkem1, Tyler Williamson2, Scott Patten2, John A Queenan1, Sabrina T Wong3, Donna Manca4, David Barber1.   

Abstract

PURPOSE: The purpose of this study was to describe the trends and patterns of antidepressant (AD) prescribing to children and adolescents in Canadian primary care before and after the black-box warning in 2004.
METHODS: Prescription data from the Canadian Primary Care Sentinel Surveillance Network, a repository of primary care data on over 1 million patients, was used to analyze AD prescribing to children (8-11 y) and adolescents (12-18 y) between 2000 and 2014. Interrupted time series analyses were used to assess the impact of the 2004 black-box warning on the prescribing levels of ADs.
RESULTS: The 2004 black-box warning had a significant and immediate effect on the prescribing of AD. However, this drop was not sustained, and 5 years after the advisory AD prescribing rates reversed direction and started to rise. Selective serotonin reuptake inhibitors dominated as the most common AD prescribed throughout the study period, increasing from 66% prior to the black-box warning to 83.12% after 2009.
CONCLUSIONS: The black-box warning effectively reduced AD prescribing in primary care for approximately 5 years before a reversal back to a positive rate of prescribing. This rebounding could reflect an emerging consensus about the trade-off in risks and benefits.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  antidepressant drugs; children; database; depression; electronic medical records; primary care

Mesh:

Substances:

Year:  2017        PMID: 28594077     DOI: 10.1002/pds.4240

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  6 in total

1.  Transgenerational hypocortisolism and behavioral disruption are induced by the antidepressant fluoxetine in male zebrafish Danio rerio.

Authors:  Marilyn N Vera-Chang; Antony D St-Jacques; Rémi Gagné; Chris J Martyniuk; Carole L Yauk; Thomas W Moon; Vance L Trudeau
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-10       Impact factor: 11.205

2.  Serotonin Syndrome in Children and Adolescents Exposed to Selective Serotonin Reuptake Inhibitors - A Review of Literature.

Authors:  Siqi Xuev; Abel Ickowicz
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2021-08-01

3.  Improving care for elderly patients living with polypharmacy: protocol for a pragmatic cluster randomized trial in community-based primary care practices in Canada.

Authors:  M Greiver; S Dahrouge; P O'Brien; D Manca; M T Lussier; J Wang; F Burge; M Grandy; A Singer; M Twohig; R Moineddin; S Kalia; B Aliarzadeh; N Ivers; S Garies; J P Turner; B Farrell
Journal:  Implement Sci       Date:  2019-06-06       Impact factor: 7.327

4.  Fluoxetine Exposure During Sexual Development Disrupts the Stress Axis and Results in Sex- and Time- Dependent Effects on the Exploratory Behavior in Adult Zebrafish Danio rerio.

Authors:  Marilyn N Vera-Chang; Antony D St-Jacques; Chunyu Lu; Thomas W Moon; Vance L Trudeau
Journal:  Front Neurosci       Date:  2019-09-19       Impact factor: 4.677

5.  Effects of COVID-19 pandemic on anxiety and depression in primary care: A retrospective cohort study.

Authors:  Ellen Stephenson; Braden O'Neill; Sumeet Kalia; Catherine Ji; Noah Crampton; Debra A Butt; Karen Tu
Journal:  J Affect Disord       Date:  2022-02-06       Impact factor: 4.839

6.  Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents.

Authors:  Jenny W Sun; Sonia Hernández-Díaz; Sebastien Haneuse; Florence T Bourgeois; Seanna M Vine; Mark Olfson; Brian T Bateman; Krista F Huybrechts
Journal:  JAMA Psychiatry       Date:  2021-01-01       Impact factor: 21.596

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.